North-America Contract Research Organization (CRO) Services Market By Type (Preclinical, Clinical Research, Laboratory), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceutical, Biopharmaceutical & Medical Device Companies), And By Region – North-America Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018 To 2023)

North-America Contract Research Organization (CRO) Services Market By Type (Preclinical, Clinical Research, Laboratory), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceutical, Biopharmaceutical & Medical Device Companies), And By Region – North-America Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018 To 2023)

ID: 7202 | Pages: 145 | April 2018 | Region: North America


Contract research organization primarily work in the field of biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance. Companies that wish to enter biotechnology, and medical device industries often hire CROs on contract basis to get a comprehensive research of the market. They are not only very useful but are also cost-effective and provides companies with research in affordable prices. Nowadays, government organizations and even private research foundations are heavily outsourcing their research work to CROs due to their quality of work, cost-effectiveness and short delivery period.

North-America Contract Research Organization (CRO) Services market is anticipated to grow at a 6.02% CAGR from 2018 to 2023 and it is estimated that the North-America market was valued at USD 13.84 billion in 2018 and is expected to reach USD 18.54 billion by 2023.

Growing R&D expenditure, rise in outsourcing of R&D activities, growing demand for outsourcing analytical testing and clinical trial services, and rise in the number of clinical trials are expected to drive the growth of this market. Moreover, the high risk of failure in clinical trials is also expected to trigger the demand for CROs by pharmaceutical and biopharmaceutical vendors to outsource their R&D. However, rising regulatory pressure on CROs can hinder their market growth to a certain extent. Furthermore, factors such as difficulty in finding personnel with expertise for specific projects and unavailability of highly skilled experts are going to hinder the growth of the market. But, rise in the cases of diseases such as cardiovascular, diabetes, and oncological has led to rise in the emphasis on innovative treatment therapies for existing as well upcoming diseases, growing demand for outsourcing analytical testing, and optimal service provided by the CROs are going to aid market growth.

The North-America market for Contract Research Organization Services market is segmented into Type, therapeutic area, and end user. On the basis of type, it is segmented into Preclinical, Clinical Research and Laboratory. Clinical research services account for the largest share of this market segment. The laboratory services segment is anticipated to witness the highest growth mainly due to the rise in subcontracting of analytical and bioanalytical testing services by pharmaceutical and biopharmaceutical companies and medical device companies. On the basis of therapeutic area, it is segmented into Oncology, CNS, and Cardiovascular.  The oncology segment has the largest share in this market segment. It is mainly due to factors such as rise in the prevalence of cancer worldwide and rises in the number of clinical trials conducted for oncology. On the basis of end user, it is segmented into Pharmaceutical, Biopharmaceutical and Medical Device Company. Pharmaceutical and biopharmaceutical held the largest share in this market segment. To boost profit margins, avoid high capital expenditure, and reduce the time of drug development, pharmaceutical and biopharmaceutical have risen the outsourcing of early-phase development services, clinical research, and laboratory testing services thereby by propelling the growth of the market.

On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North America held the largest share in the global market. The large share of this regional segment can be attributed to the high-quality standards in pharmaceutical industry, rapid growth in the biosimilars and biologics market, surge in the demand for outsourcing of services by pharmaceutical and biopharmaceutical companies, and rise in the number of clinical trials in this region. Furthermore, heavy investment by U.S. government in R&D of medical care is further expected to boost the market.

The market is mainly dominated by companies such as Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, PAREXEL International Corporation, ICON Plc, PRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Type                                              

                                5.1.1 Introduction                           

                                5.1.2 Clinical Research Services                 

                                                5.1.2.1 Phase I Clinical Research Services              

                                                5.1.2.2 Phase II Clinical Research Services             

                                                5.1.2.3 Phase III Clinical Research Services           

                                                5.1.2.4 Phase IV Clinical Research Services           

                                5.1.3 Early-Phase Development Services                              

                                                5.1.3.1 Discovery Studies             

                                                5.1.3.2 Chemistry, Manufacturing, & Control (CMC)        

                                                5.1.3.3 Preclinical Services           

                                                                5.1.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)

                                                                5.1.3.3.2 Toxicology Testing Services

                                                                5.1.3.3.3 Other Preclinical Services

                                5.1.4 Laboratory Services                             

                                                5.1.4.1 Bioanalytical Testing Services      

                                                5.1.4.2 Analytical Testing Services            

                                                                5.1.4.2.1 Physical Characterization

                                                                5.1.4.2.2 Raw Material Testing

                                                                5.1.4.2.3 Batch-Release Testing

                                                                5.1.4.2.4 Stability Testing

                                                                5.1.4.2.5 Other Analytical Testing Services

                                5.1.5 Consulting Services                             

                                5.1.6 Y-o-Y Growth Analysis, By Product                               

                                5.1.7  Market Attractiveness Analysis, By Product                            

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Therapeutic Area                                     

                                5.2.1 Introduction                           

                                5.2.2 Oncology                 

                                5.2.3 CNS                            

                                5.2.4 Cardiovascular                       

                                5.2.5 Y-o-Y Growth Analysis, By Therapeutic Area                            

                                5.2.6 Market Attractiveness Analysis, By Therapeutic Area                          

                                5.2.7 Market Share Analysis, By Therapeutic Area                            

                5.3 End User                                      

                                5.3.1 Introduction                           

                                5.3.2 Pharmaceutical                     

                                5.3.3 Biopharmaceutical                               

                                5.3.4 Medical Device Companiest                            

                                5.3.5 Y-o-Y Growth Analysis, By End User                             

                                5.3.6  Market Attractiveness Analysis, By End User                          

                                5.3.7  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Therapeutic Area        

                                                6.1.3.3 By Type 

                                                6.1.3.4 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Therapeutic Area        

                                                6.1.4.3 By End User        

                                                6.1.4.4 By Application    

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Therapeutic Area        

                                                6.1.5.3 By Type 

                                                6.1.5.4 By End User        

                6.2 United States                                            

                6.3 Canada                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Quintiles Transnational Holdings Inc.                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Laboratory Corporation of America Holdings                                               

                8.3 Pharmaceutical Product Development                                           

                8.4 PAREXEL International Corporation                                  

                8.5 ICON Plc                                       

                8.6 PRA Health Sciences Inc.                                       

                8.7 InVentiv Health Inc.                                

                8.8 Charles River Laboratories International Inc.                                

                8.9 INC Research Holdings Inc.                                  

                8.10 Wuxi PharmaTech.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Composite type, by End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

TitlePriceAdd To Cart
  1. North America Contract Research Organization Services  Market By Type, From 2018-2023 ( USD Billion )
  2. North America Preclinical Market By Region, From 2018-2023 ( USD Billion )
  3. North America Clinical Research Market By Region, From 2018-2023 ( USD Billion )
  4. North America Laboratory Market By Region, From 2018-2023 ( USD Billion )
  5. North America Contract Research Organization Services  Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  6. North America Oncology Market By Region, From 2018-2023 ( USD Billion )
  7. North America CNS Market By Region, From 2018-2023 ( USD Billion )
  8. North America Cardiovascular Market By Region, From 2018-2023 ( USD Billion )
  9. North America Contract Research Organization Services  Market By End User, From 2018-2023 ( USD Billion )
  10. North America Pharmaceutical Market By Region, From 2018-2023 ( USD Billion )
  11. North America Biopharmaceutical Market By Region, From 2018-2023 ( USD Billion )
  12. North America Medical Device Companie Market By Region, From 2018-2023 ( USD Billion )
  13. United States Contract Research Organization Services  Market By Type, From 2018-2023 ( USD Billion )
  14. United States Contract Research Organization Services  Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  15. United States Contract Research Organization Services  Market By End User, From 2018-2023 ( USD Billion )
  16. Canada Contract Research Organization Services  Market By Type, From 2018-2023 ( USD Billion )
  17. Canada Contract Research Organization Services  Market By Therapeutic Area, From 2018-2023 ( USD Billion )
  18. Canada Contract Research Organization Services  Market By End User, From 2018-2023 ( USD Billion )
Middle East And Africa Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequen...
Latin America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Asia-pacific Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targ...
Europe Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted G...
North America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted Gene Seq...
Middle East And Africa Platelet Rich Plasma Market By Application (Orthopaedics, Cos0metic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Ind...
Latin America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Asia-Pacific Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Si...
Europe Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Size, Sh...
North America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Platelet Rich Plasma Market -Segmented By Product Type, Application, And Region - Global Growth, Trends, And Forecast -2023...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.